Quarterly Consolidated Statement Of Cash Flows

TAKARA BIO INC. - Filing #7256073

Concept As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-03-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
5,576,000,000 JPY
4,361,000,000 JPY
Interest and dividends received
285,000,000 JPY
166,000,000 JPY
Interest paid
-20,000,000 JPY
-22,000,000 JPY
Net cash provided by (used in) operating activities
5,844,000,000 JPY
1,711,000,000 JPY
Cash flows from investing activities
Other, net
1,000,000 JPY
-19,000,000 JPY
Net cash provided by (used in) investing activities
-10,912,000,000 JPY
-13,043,000,000 JPY
Cash flows from financing activities
Dividends paid
-2,048,000,000 JPY
-5,052,000,000 JPY
Other, net
0 JPY
JPY
Net cash provided by (used in) financing activities
-2,256,000,000 JPY
-5,233,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
1,190,000,000 JPY
678,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-6,134,000,000 JPY
-15,886,000,000 JPY
Cash and cash equivalents
27,036,000,000 JPY
33,171,000,000 JPY
49,058,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.